Document Detail


Analysis of signaling pathways related to cell proliferation stimulated by insulin analogs in human mammary epithelial cell lines.
MedLine Citation:
PMID:  19153208     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Insulin and insulin analogs stimulate proliferation of human mammary epithelial cells. We identified and analyzed the signaling pathways related to cell proliferation induced by regular insulin and by four insulin analogs presently approved for therapeutical use. Benign and malignant mammary cell lines showing different insulin receptor (IR) and IGF-I receptor (IGF-IR) expression patterns were studied. Cell proliferation was studied by crystal violet staining (BrdU-FACS analysis). Activation of insulin and IGF signaling pathways was studied by analysis of the phosphorylation status of IGF-IR and of key signaling proteins of the phosphoinositide 3-kinase (PI3K)/Akt and MAP kinase pathways, by the use of specific PI3K and MAP kinase inhibitors, and by silencing of IR and IGF-IR. Lantus stimulated the growth of MCF7 cells, which show high IGF-IR/IR ratio, significantly at 0.3 nmol/l, while regular insulin (Actrapid and bovine insulin) and other insulin analogs (Novorapid, Humalog, and Levemir) stimulated cell growth at 1.5-15 nmol/l concentrations. No difference between Lantus and the other insulin analogs was observed regarding growth stimulation of MCF10A cells showing low IGF-IR/IR ratio. Growth stimulation of MCF7 cells by Lantus was mainly due to strong activation of the IGF-IR and the MAP kinase pathway. Regular insulin and other insulin analogs tested activated mainly the IR and the PI3K/Akt pathway. We conclude that unlike regular insulin and other insulin analogs, Lantus strongly activates the IGF-IR and the MAP kinase pathway in MCF7 cells and is a strong mitogen for cells characterized by a high-IGF-IR/IR ratio.
Authors:
Ashish Shukla; Jean Grisouard; Volker Ehemann; Alexander Hermani; Harald Enzmann; Doris Mayer
Related Documents :
7947248 - Reversal of diabetes associated with escape of myeloma: evidence for inappropriate igf-...
11572888 - Effects of the somatostatin analogue octreotide on renal function in conscious diabetic...
7581968 - Resting metabolic rate, body composition and related hormonal parameters in growth horm...
8081988 - Insulin-like growth factor-i and experimental diabetic kidney disease.
24065788 - Sugar, uric acid, and the etiology of diabetes and obesity.
8363568 - Restoration in vitro of normal rates of very-low-density lipoprotein triacylglycerol an...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2009-01-19
Journal Detail:
Title:  Endocrine-related cancer     Volume:  16     ISSN:  1351-0088     ISO Abbreviation:  Endocr. Relat. Cancer     Publication Date:  2009 Jun 
Date Detail:
Created Date:  2009-05-29     Completed Date:  2009-07-16     Revised Date:  2009-11-19    
Medline Journal Info:
Nlm Unique ID:  9436481     Medline TA:  Endocr Relat Cancer     Country:  England    
Other Details:
Languages:  eng     Pagination:  429-41     Citation Subset:  IM    
Affiliation:
Hormones and Signal Transduction Group, German Cancer Research Center, DKFZ-ZMBH Alliance, 69120 Heidelberg, Germany.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
1-Phosphatidylinositol 3-Kinase / genetics,  metabolism
Animals
Breast Neoplasms / drug therapy,  metabolism*,  pathology*
Cattle
Cell Proliferation / drug effects*
Enzyme Inhibitors / pharmacology
Female
Humans
Immunoblotting
Insulin / analogs & derivatives*,  pharmacology*
MAP Kinase Signaling System / drug effects
Mammary Glands, Human / metabolism
Phosphorylation / drug effects
Proto-Oncogene Proteins c-akt / genetics,  metabolism
RNA, Messenger / genetics,  metabolism
RNA, Small Interfering / pharmacology
Receptor, IGF Type 1 / antagonists & inhibitors,  genetics,  metabolism
Receptor, Insulin / genetics,  metabolism
Reverse Transcriptase Polymerase Chain Reaction
Signal Transduction / drug effects*
Tumor Cells, Cultured
Chemical
Reg. No./Substance:
0/Enzyme Inhibitors; 0/RNA, Messenger; 0/RNA, Small Interfering; 11061-68-0/Insulin; EC 2.7.1.137/1-Phosphatidylinositol 3-Kinase; EC 2.7.10.1/Receptor, IGF Type 1; EC 2.7.10.1/Receptor, Insulin; EC 2.7.11.1/Proto-Oncogene Proteins c-akt

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Evidence based medical imaging (EBMI).
Next Document:  Array-comparative genomic hybridization in sporadic benign pheochromocytomas.